Clinical trial: effects of an oral preparation of mesalazine at 4 g/day on moderately active ulcerative colitis. A phase III parallel-dosing study

Author: Hiwatashi Nobuo   Suzuki Yasuo   Mitsuyama Keiichi   Munakata Akihiro   Hibi Toshifumi  

Publisher: Springer Publishing Company

ISSN: 0944-1174

Source: Journal of Gastroenterology, Vol.46, Iss.1, 2011-01, pp. : 46-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content